Skip to main content
Annals of Translational Medicine logoLink to Annals of Translational Medicine
. 2024 Nov 8;13(4):49. doi: 10.21037/atm-2024-22

Erratum to downregulation of miR-182-5p inhibits the proliferation and invasion of triple-negative breast cancer cells through regulating TLR4/NF-κB pathway activity by targeting FBXW7

Editorial Office1
PMCID: PMC12432661  PMID: 40949681

This article (1) titled “Downregulation of miR-182-5p inhibits the proliferation and invasion of triple-negative breast cancer cells through regulating TLR4/NF-κB pathway activity by targeting FBXW7” (doi: 10.21037/atm-20-5192) unfortunately contains errors in Figures 2,4. The NC group in Figure 2E is a duplicate of the FBXW7 group in Figure 4E, and the NC group in Figure 2F is a duplicate of the FBXW7 group in Figure 4F.

Figures 2E,4E and Figures 2F,4F of the original article:

graphic file with name atm-13-04-49-fig1.jpg

The correct version of Figure 2.

graphic file with name atm-13-04-49-fig2.jpg

The correct version of Figure 4.

graphic file with name atm-13-04-49-fig3.jpg

The authors confirmed this error did not significantly affect either the results or the conclusions of the paper.

Click here to view the updated version of the article.

Supplementary

The article’s supplementary files as

DOI: 10.21037/atm-2024-22

References

  • 1.Wu X, Chen H, Wu M, et al. Downregulation of miR-182-5p inhibits the proliferation and invasion of triple-negative breast cancer cells through regulating TLR4/NF-κB pathway activity by targeting FBXW7. Ann Transl Med 2020;8:995. 10.21037/atm-20-5192 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

The article’s supplementary files as

DOI: 10.21037/atm-2024-22

Articles from Annals of Translational Medicine are provided here courtesy of AME Publications

RESOURCES